More export problems at 3M

We watch closely for signs that previously unknown criminal and regulatory inquiries are underway, or that existing inquiries have worsened. We’ve had some good success: In February 2012, we warned that investigations into United Technology’s (UTX) role in helping China build an attack helicopter had become a more serious issue for the company [PDF]. …

QuickTake: Lions Gate Entertainment’s botched financials

Movie distributor Lions Gate Entertainment (LGF) just filed an amendment to its 10-K disclosing, in a roundabout way, that it was restating elements of its cash-flow statement, as well as the material weakness in its controls that allowed the original error. From a quick read, it looks like the company miscategorized more than $50 million […]

QuickTake: Ralcorp’s tricky restatement

Late yesterday, Ralcorp (RAH) filed one of the most confusing 8-Ks that we’ve come across in a long time. Because we firmly believe that there are no accidents when it comes to SEC filings, we thought it was worth putting out a QuickTake, even though the headline — yet another accounting restatement for …

The SEC takes Amazon to task for cyber security

First, some quick background: Last October, the SEC issuednew guidance on how companies were supposed to disclose both risks and problems related to cyber-security. We started tracking those disclosures shortly after that guidance came out and it’s largely been a big snore-fest. At the overwhelming majority of companies, this has led to some additional …

DaVita’s goodwill assumptions

DaVita (DVA) is the country’s second-biggest kidney dialysis provider, and despite its planned expansion — in May, it announced plans to acquire HealthCare Partners, a big medical group and doctor network — most of its revenue is likely to come from its 1,800-plus dialysis centers. As a result, we think investors should take note of […]

10-Q roundup (and more): J&J, MoneyGram, Aecom, Juniper Networks & QEP Resources 

During the thick of 10-Q filings season, we sent a number of QuickTakes out. But now that we’ve had a chance to catch our breath, we wanted to go back and highlight some of the more significant disclosures that didn’t quite warrant a QuickTake, but seemed more significant to us than just including in the […]

Mounting problems at Accretive Health

It’s been a tough few weeks for investors in Accretive Health (AH). The stock has fallen 42% since April 24, when this story appeared in The New York Times, highly critical of some of the company’s techniques for collecting overdue patient accounts (its primary business). That same day, Minnesota Attorney General Lori Swanson, who filed …

QuickTake: FTC quizzes Impax, Medicis & more on generics pact

We’re a little surprised that this apparently hasn’t been picked up by the wire services yet, since it looks like it could be a big deal. The Federal Trade Commission has apparently sent civil investigative demands to multiple pharmaceutical companies, including Impax Laboratories (IPXL) and Medicis Pharmaceutical (MRX), over an agreement the companies reached on […]

QuickTake: Two new investigations at CACI International

Another short but sweet item, from the 10-Q that CACI International (CACI) filed on Friday afternoon. This was in the Red Flag Alert PDF we sent out last night, but we haven’t seen any reporting on these developments, so we figure it’s still fresh (and potentially significant) enough to send as a QuickTake as …

QuickTake: A subpoena for Baxter International

Medical-device maker Baxter International (BAX) is in the process of wrapping up a recall of its COLLEAGUE and SYNDEO infusion pumps that the federal government sought to seize back in 2005, under a consent decree with the Food and Drug Administration and the U.S. Justice Department (PDF) signed in 2006, and a final …